Trial Profile

Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Faricimab (Primary) ; Ranibizumab
Indications Diabetic macular oedema; Wet age-related macular degeneration
Focus Therapeutic Use
Acronyms VOYAGER; VOYAGER STUDY
Sponsors Roche

Most Recent Events

14 Jan 2025 Planned End Date changed from 31 Dec 2027 to 13 Sep 2027.
19 Sep 2024 Planned number of patients changed from 5000 to 6000.
08 Dec 2022 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com